Solubility enhancement of simvastatin: A review

Acta Poloniae Pharmaceutica - Drug Research

Volumn 69, Issue 4, 2012, Pages 581-590

  Murtaza, Ghulam ^a  

^a Tobe Camp University Road Abbottabad   (Pakistan)

Author keywords

Absorption; Bioavailability; Polymers; Solubility; Surfactants; Techniques

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ALPHA CYCLODEXTRIN; BETA CYCLODEXTRIN; GAMMA CYCLODEXTRIN; MACROGOL; MACROGOL 4000; MACROGOL 6000; MEVINOLIN; POVIDONE; SIMVASTATIN;

CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; EMULSION; EVAPORATION; FREEZE DRYING; HYDROPHILIC CONTACT LENS; HYDROPHOBICITY; INFRARED SPECTROSCOPY; MICROEMULSION; MICROWAVE IRRADIATION; NEBULIZATION; PARTICLE SIZE; PRECIPITATION; REVIEW; SURFACE TENSION;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DOSAGE FORMS; EXCIPIENTS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTESTINAL ABSORPTION; PARTICLE SIZE; SIMVASTATIN; SOLUBILITY; SURFACE-ACTIVE AGENTS; TECHNOLOGY, PHARMACEUTICAL;

EID: 84864026670     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Rinaki E., Valsami G., Macheras P.: Pharm. Res. 20, 1917 (2003).
2. Stella V., Borchardt R., Hageman M., Oliyai R., Maag H., Tilley J.: Biotechnology: Pharmaceuitical Aspects, vol. 5 (part 2), Springer, New York 2007.
3. Lindenberg M., Kopp S., Dressman J.: Eur. J. Pharm. Biopharm. 58, 265 (2004).
4. th edn., Sinko P.J. Ed., Lippincott Williams & Wilkins, Philadelphia 2006.
5. rd edn., Swarbrick J. Ed., Informa Healthcare, New York 2006.
6. Shinde A.: Pharminfo.net 5, 49 (2007).
7. Maggon K.: Drug Discov. Today, 10, 739 (2005).
8. Charman W.N.: Lipid vehicle and formulation effects on intestinal lymphatic drug transport. in: Lymphatic Transport of Drugs, Charman W.N., Stella V.J. Eds., CRC Press, Boca Raton 1992.
9. Khoo S.M., Humberstone A.J., Porter C.J.H., Edwards G.A., Charman W.N.: Int. J. Pharm. 167, 155 (1998).
10. Rawat S. Jain S.K.: Eur. J. Pharm. Biopharm. 57, 263 (2004).
11. Chandra A.: Pharminfo.net 6, 34 (2008).
12. th edn., Lea & Febiger, Pennsylvania 1993.
13. Uekama K., Hirayama F., Irie T.: Chem. Rev. 98, 2045 (1998).
14. Adel M., Mazen K.A., Qato K., Ahmad M.O.: Pharm. Technol. 54, 567 (2003).
15. Rawat S., Jain S.K.: Pharmazie 58, 639 (2003).
16. Doijad R.C., Kanakal M.M., Manvi I.V.: Indian Pharmacist 8, 94 (2007).
17. Wen X., Tan F., Jing Z., Iiu Z.: J. Pharm. Biomed. Anal. 34, 517 (2004).
18. Varshosaz, J., Tavakoli, N., Salamat, F.A.: Pharm. Dev. Technol. 16, 529 (2011).
19. Shiralashetti S., Patil A., Patil J.: Int. J. Chem. Tech. Res. 2, 562 (2010).
20. Baboota S., Bhaliwal M., Kohli K.: AAPS PharmSciTech. 6, article 14, E83 (2005).
21. Parikh R.K., Mansuri N.S., Gohel M.C., Sonlwala M.M.: Indian Drugs 42, 149 (2005).
22. Fernandes C.M., Veiga F.J.B.: Chem. Pharm. Bull. 50, 1597 (2002).
23. Rangoni M.C., Maestrelli F., Corti G., Mura P.: Drug Dev. Ind. Pharm. 31, 697 (2005).
24. Cunha-Filho M.S.S., Dacunha-Marinho B., Torres-Labandeira J.J., Martinez-Pacheco R., Landin M.: AAPS PharmSciTech. 8, 1 (2007).
25. Mandal D., Ojha P.K., Nandy B.C., Ghosh L.K.: Der Pharmacia Lettre, 2, 47 (2010).
26. Jun S.W., Kim M.S., Kim J.S., Park H.J., Lee S., Woo J.S., Hwang S.J.: Eur. J. Pharm. Biopharm. 66, 413 (2007).
27. Gupta P., Kakumanu V.K., Bansal A.K.: Pharm. Res. 21, 1762 (2004).
28. Abdul-Fattah A.M., Bhargava H.N.: Int. J. Pharm. 235, 17 (2002).
29. Sinha S., Ali, M., Baboota S., Ahuja A., Kumar A., Ali J.: AAPS PharmSciTech. 11, 518 (2010).
30. Zhang Y., Zhang J., Jiang T., Wang S.: Int. J. Pharm. 410, 118 (2011).
31. Chaumeil J.C.: Methods Findings Exp. Clin. Pharmacol. 20, 211 (1998).
32. Blagden N., Matas M., de Gavan P.T., York P.: Adv. Drug Deliv. Rev. 59, 617 (2007).
33. Alonso M.J., Cohen S., Bernstein H.: Nanoparticulate drug carrier technology. in Microparticulate Systems for the Delivery of Proteins and Vaccines. Marcel Dekker, New York 1996.
34. Pandya P., Gattani S., Jain P., Khirwal L., Surana S.: AAPS PharmSciTech. 9, 1247 (2008).
35. Silva T.D., Resende J.A.L.C., Arantes V.T., Speziali N.L., de Oliveira R.B., Vianna-Soares C.D.: Drug Dev. Ind. Pharm. 36, 1348 (2010).
36. Zhang F. Aaltonen J., Tian F., Saville D.J., Rades T.: Eur. J. Pharm. Biopharm. 71, 64 (2009).
37. Ambike A.A., Mahadik K.R.: Pharm. Res. 22, 990 (2008).
38. Margulis-Goshen K., Magdassi S.: Nanomed. Nanotechnol. Biol. Med. 5, 274 (2009).
39. Meng, J. Zheng, L.: Drug Dev. Ind. Pharm. 33, 927 (2007).
40. Lee B., Park M., Choi C.: AAPS J. 34, S1 (2003).
41. Ding, Z., Hao, A., Zhang, P.: J. Dispers. Sci. Technol. 28, 495 (2007).
42. Oh D., Lee B.: J. Chem. Eng. Data 52, 1273 (2007).
43. Patel R., Baria A., Patel N.: Asian J. Pharm. 2, 216 (2008).
44. Zimper U., Aaltonen J., Krauel-Goellner K., Gordon K.C. Strachan, C.J., Rades T.: Pharmaceutics 2, 419 (2010).
45. Patil, M.S., Bavaskar, K.R., Girnar, G.A., Jain, A.S., Tekade, A.R.: Int. J. Pharma Res. Dev. 2, 219 (2011).